Su Yao, Chen Lin, Yang Jin
College of Pharmacy, Chengdu University, 2025 Chengluo Avenue., Cheng Du, CD 610000, China.
Department of Urology Surgery, Affiliated Hospital&Clinical Medical College of Chengdu University, 82 North Second Section of the Second Ring Road., Chengdu, CD 610000,China.
Curr Cancer Drug Targets. 2025 Jan 7. doi: 10.2174/1568009623666230706153936.
Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn from the journal Current Cancer Drug Targets. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultane-ously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
由于作者未回应编辑为满足编辑要求而提出的请求,因此,该文章已从《当代癌症药物靶点》期刊撤回。本瑟姆科学出版社就此事可能给期刊读者带来的不便深表歉意。关于文章撤回的本瑟姆编辑政策可在https://benthamscience.com/editorial-policies-main.php查询。
提交至本期刊的稿件未在其他地方发表且不会同时提交或发表于其他地方,这是发表的条件。此外,已在其他地方发表的任何数据、插图、结构或表格都必须报告,并必须获得复制的版权许可。严禁抄袭,提交文章以供发表即表示作者同意,如果发现抄袭或虚假信息,出版方有权对作者采取适当行动。提交稿件即表示作者同意,若文章被接受发表,其文章版权将转让给出版方。